Virág Bogdándi1, Tomoaki Ida2, Thomas R Sutton3, Christopher Bianco4, Tamás Ditrói1, Grielof Koster3, Hillary A Henthorn5, Magda Minnion3, John P Toscano4, Albert van der Vliet6, Michael D Pluth5, Martin Feelisch3, Jon M Fukuto7, Takaaki Akaike2, Péter Nagy1. 1. Department of Molecular Immunology and Toxicology, National Institute of Oncology, Budapest, Hungary. 2. Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan. 3. Clinical and Experimental Sciences, Faculty of Medicine, University Hospital Southampton NHS Foundation Trust, University of Southampton, Southampton, UK. 4. Department of Chemistry, Johns Hopkins University, Baltimore, MD, USA. 5. Department of Chemistry and Biochemistry, Materials Science Institute, Institute of Molecular Biology, University of Oregon, Eugene, OR, USA. 6. Department of Pathology and Laboratory Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA. 7. Department of Chemistry, Sonoma State University, Rohnert Park, CA, USA.
Abstract
BACKGROUND AND PURPOSE: Posttranslational modifications of cysteine residues represent a major aspect of redox biology, and their reliable detection is key in providing mechanistic insights. The metastable character of these modifications and cell lysis-induced artifactual oxidation render current state-of-the-art protocols to rely on alkylation-based stabilization of labile cysteine derivatives before cell/tissue rupture. An untested assumption in these procedures is that for all cysteine derivatives, alkylation rates are faster than their dynamic interchange. However, when the interconversion of cysteine derivatives is not rate limiting, electrophilic labelling is under Curtin-Hammett control; hence, the final alkylated mixture may not represent the speciation that prevailed before alkylation. EXPERIMENTAL APPROACH: Buffered aqueous solutions of inorganic, organic, cysteine, GSH and GAPDH polysulfide species were used. Additional experiments in human plasma and serum revealed that monobromobimane can extract sulfide from the endogenous sulfur pool by shifting speciation equilibria, suggesting caution should be exercised when interpreting experimental results using this tool. KEY RESULTS: In the majority of cases, the speciation of alkylated polysulfide/thiol derivatives depended on the experimental conditions. Alkylation perturbed sulfur speciation in both a concentration- and time-dependent manner and strong alkylating agents cleaved polysulfur chains. Moreover, the labelling of sulfenic acids with dimedone also affected cysteine speciation, suggesting that part of the endogenous pool of products previously believed to represent sulfenic acid species may represent polysulfides. CONCLUSIONS AND IMPLICATIONS: We highlight methodological caveats potentially arising from these pitfalls and conclude that current derivatization strategies often fail to adequately capture physiological speciation of sulfur species. LINKED ARTICLES: This article is part of a themed section on Chemical Biology of Reactive Sulfur Species. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.
BACKGROUND AND PURPOSE: Posttranslational modifications of cysteine residues represent a major aspect of redox biology, and their reliable detection is key in providing mechanistic insights. The metastable character of these modifications and cell lysis-induced artifactual oxidation render current state-of-the-art protocols to rely on alkylation-based stabilization of labile cysteine derivatives before cell/tissue rupture. An untested assumption in these procedures is that for all cysteine derivatives, alkylation rates are faster than their dynamic interchange. However, when the interconversion of cysteine derivatives is not rate limiting, electrophilic labelling is under Curtin-Hammett control; hence, the final alkylated mixture may not represent the speciation that prevailed before alkylation. EXPERIMENTAL APPROACH: Buffered aqueous solutions of inorganic, organic, cysteine, GSH and GAPDHpolysulfide species were used. Additional experiments in human plasma and serum revealed that monobromobimane can extract sulfide from the endogenous sulfur pool by shifting speciation equilibria, suggesting caution should be exercised when interpreting experimental results using this tool. KEY RESULTS: In the majority of cases, the speciation of alkylated polysulfide/thiol derivatives depended on the experimental conditions. Alkylation perturbed sulfur speciation in both a concentration- and time-dependent manner and strong alkylating agents cleaved polysulfur chains. Moreover, the labelling of sulfenic acids with dimedone also affected cysteine speciation, suggesting that part of the endogenous pool of products previously believed to represent sulfenic acid species may represent polysulfides. CONCLUSIONS AND IMPLICATIONS: We highlight methodological caveats potentially arising from these pitfalls and conclude that current derivatization strategies often fail to adequately capture physiological speciation of sulfur species. LINKED ARTICLES: This article is part of a themed section on Chemical Biology of Reactive Sulfur Species. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.4/issuetoc.
Authors: Sebastián Carballal; Madia Trujillo; Ernesto Cuevasanta; Silvina Bartesaghi; Matías N Möller; Lisa K Folkes; Miguel A García-Bereguiaín; Carlos Gutiérrez-Merino; Peter Wardman; Ana Denicola; Rafael Radi; Beatriz Alvarez Journal: Free Radic Biol Med Date: 2010-10-26 Impact factor: 7.376
Authors: Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2017-12 Impact factor: 8.739
Authors: Matthew D Hartle; Daniel J Meininger; Lev N Zakharov; Zachary J Tonzetich; Michael D Pluth Journal: Dalton Trans Date: 2015-12-14 Impact factor: 4.390
Authors: Romy Greiner; Zoltán Pálinkás; Katrin Bäsell; Dörte Becher; Haike Antelmann; Péter Nagy; Tobias P Dick Journal: Antioxid Redox Signal Date: 2013-06-20 Impact factor: 8.401
Authors: David E Heppner; Milena Hristova; Tomoaki Ida; Ana Mijuskovic; Christopher M Dustin; Virág Bogdándi; Jon M Fukuto; Tobias P Dick; Péter Nagy; Jianing Li; Takaaki Akaike; Albert van der Vliet Journal: Redox Biol Date: 2017-10-09 Impact factor: 11.799
Authors: John L Wallace; Peter Nagy; Troy D Feener; Thibault Allain; Tamás Ditrói; David J Vaughan; Marcelo N Muscara; Gilberto de Nucci; Andre G Buret Journal: Br J Pharmacol Date: 2019-04-11 Impact factor: 8.739
Authors: Christopher L Bianco; Takaaki Akaike; Tomoaki Ida; Peter Nagy; Virag Bogdandi; John P Toscano; Yoshito Kumagai; Catherine F Henderson; Robert N Goddu; Joseph Lin; Jon M Fukuto Journal: Br J Pharmacol Date: 2018-06-28 Impact factor: 8.739
Authors: Virág Bogdándi; Tomoaki Ida; Thomas R Sutton; Christopher Bianco; Tamás Ditrói; Grielof Koster; Hillary A Henthorn; Magda Minnion; John P Toscano; Albert van der Vliet; Michael D Pluth; Martin Feelisch; Jon M Fukuto; Takaaki Akaike; Péter Nagy Journal: Br J Pharmacol Date: 2018-08-23 Impact factor: 8.739